Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults

British Journal of Nutrition

Volumn 110, Issue 12, 2013, Pages 2242-2249

  Nestel, Paul J ^a   Mellett, Natalie ^a   Pally, Suzana ^a   Wong, Gerard ^a   Barlow, Chris K ^a   Croft, Kevin ^b   Mori, Trevor A ^b   Meikle, Peter J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Fermented dairy foods; Inflammatory biomarkers; Lipidomics; Nutrition trials

Indexed keywords

INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; LIPID; PLASMALOGEN; SPHINGOMYELIN; YOGHURT;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BUTTER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEESE; COMPARATIVE STUDY; CREAM; CROSSOVER PROCEDURE; DAIRY PRODUCT; DIET; DISEASE MARKER; FAT INTAKE; FEMALE; FERMENTED PRODUCT; HUMAN; HUMAN EXPERIMENT; ICE CREAM; INFLAMMATION; LIPID BLOOD LEVEL; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CULTURED MILK PRODUCTS; DIETARY FATS; F2-ISOPROSTANES; FERMENTATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPIDS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 84889248703     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001621     Document Type: Article

References (35)

1. Libby P, Ridker PM & Maseri A (2002) Inflammation and atherosclerosis. Circulation 105, 1411-1415.
2. Pischon T, Hu FB, Rexrode KM, et al. (2008) Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 197, 392-399.
3. Manning P, Sutherland WHF, McGrath MM, et al. (2008) Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity 16, 2046-2052.
4. El-Khoury D, Hwaila N, Frochet V, et al. (2010) Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein. Atherosclerosis 210, 307-313.
5. Giugliano D, Ceriello A, Esposito K, et al. (2006) The effects of diet on inflammation. J Am Coll Cardiol 48, 677-685.
6. Nestel PJ, Pally S, MacIntosh GL, et al. (2012) Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods. Eur J Clin Nutr 66, 25-31.
7. Bernstein AM, Sun Q, Hu FB, et al. (2010) Major dietary protein sources and risk of coronary heart disease in women. Circulation 122, 859-860.
8. Soedehma-Mutha SS, Ding EL, Al-Delaimy WK, et al. (2011) Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: Dose-response meta-Analysis of prospective cohort studies. Am J Clin Nutr 93, 158-163.
9. Goldbohm RA, Chorus AMJ & Garre D (2011) Dairy consumption and 10-y total and cardiovascular mortality: A prospective cohort study in the Netherlands. Am J Clin Nutr 93, 615-627.
10. Nestel PJ (2012) Editorial: The changing face of the dairycardiovascular risk paradox. Curr Opin Lipidol 23, 1-3.
11. Warensjo E, Jansson J-H, Cederhol T, et al. (2010) Biomarkers of milk fat and the risk of myocardial infarction in men and women: A prospective matched case-control study. Am J Clin Nutr 92, 194-201.
12. Noakes M, Nestel PJ & Clifton PM (1996) Modifying the fatty acid profile of dairy products through feedlot technology lowers plasma cholesterol of humans consuming those products. Am J Clin Nutr 63, 42-46.
13. Elwood PC, Pickering JE, Givens DI, et al. (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: An overview of the evidence. Lipids 45, 925-939.
14. Liu S, Choi HK & Ford E (2006) A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29, 1578-1584.
15. Meikle PJ, Wong G, Tsorotes D, et al. (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31, 2723-2732.
16. Mori TA, Croft KD, Puddey JB, et al. (1999) An improved method for the measurement of urinary and plasma F2- isoprostanes using gas chromatography mass spectrometry. Anal Biochem 268, 117-125.
17. The Emerging Risk Factor Collaboration (2010) C-reactive protein and risk of coronary heart disease, stroke, and mortality: An individual participant meta-Analysis. Lancet 375, 132-140.
18. Heart Protection Study Collaborative Group (2011) C-reactive protein concentration and the vascular benefits of statin therapy: An analysis of 20,536 patients in the Heart Protection Study. Lancet 377, 469-476.
19. Cesari M, Pennix WJH, Newman AB, et al. (2003) Inflammatory markers and onset of cardiovascular events. Circulation 108, 2317-2322.
20. Tzoulaki I, Murray GD, Lee AJ, et al. (2005) C-reactive protein, interleukin-6 and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112, 976-983.
21. Empana J-P, Canoui-Poitrine F, Luc G, et al. (2008) Contribution of novel biomarkers to incident acute coronary syndrome: The PRIME Study. Eur Heart J 29, 1966-1974.
22. Hoogveen RC, Morrison A, Boerwinkle E, et al. (2005) Plasma MCP-1 level and risk for peripheral atherosclerosis and incident coronary heart disease: Atherosclerosis Risk in Communities Study. Atherosclerosis 183, 301-307.
23. Depurkar R, Ghanim M, Friedman J, et al. (2010) Differential effects of cream, glucose and orange juice on inflammation, endotoxin and the expression of Toll like receptor-4 and suppressor of cytokine signalling-3. Diabetes Care 33, 1013-1017.
24. Kelly KR, Haus JM, Solomon TPJ, et al. (2011) A low-glycemic index diet and exercise intervention reduces TNFa in isolated mononuclear cells in older, obese adults. J Nutr 141, 1089-1094.
25. Van Meiji LEC & Mensink RP (2010) Effects of low-fat dairy consumption on markers of low-grade inflammation and endothelial function in overweight and obese subjects: An intervention study. Br J Nutr 104, 1523-1527.
26. Jiang XC, Paultre F, Pearson TA, et al. (2000) Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 20, 2614-2618.
27. Nelson JC, Jiang XC, Tabas I, et al. (2006) Plasma sphingomyelin and subclinical atherosclerosis findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol 163, 903-912.
28. Stegemann C, Drozdov I, Shalhoub J, et al. (2011) Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet 4, 232-242.
29. Bolin DJ & Jonas A (1996) Sphingomyelin inhibits the lecithin cholesterol acyl transferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem 271, 1915-1918.
30. Skaff O, Pattison DI & Davies MJ (2008) The vinyl ether linkages of plasmalogens are favoured targets for the myeloperoxidase- derived oxidants: A kinetic study. Biochemistry 47, 8237-8245.
31. Meisinger C, Baumert J, Khuseyinova N, et al. (2005) Plasma oxidised low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middleaged men from the general population. Circulation 112, 651-657.
32. Stancliffe RA, Thorpe T & Zemel MB (2011) Dairy attenuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr 94, 422-430.
33. Panagiotacos N, Pitsavos CH, Zampelas AD, et al. (2010) Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults. J Am Coll Nutr 29, 357-364.
34. Wennersberg MH, Smedman A, Turpeinen AM, et al. (2009) Dairy products and metabolic effects in overweight men and women: Results from 6-mo intervention study. Am J Clin Nutr 90, 960-968.
35. Sluijs I, Forouhi NG, Beulens JWJ, et al. (2012) The amount and type of dairy product intake and incident type 2 diabetes: Results from the EPIC-InterAct Study. Am J Clin Nutr 96, 382-390.